David W. Feigal is a Principal in NDA Partners, LLC. He teaches food and drug law and policy at the College of Law, and is an adjunct professor at the Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.
Professor Feigal has previously served as Vice President for Global Regulatory Affairs at Amgen, Inc., and as Senior Vice President for Global Regulatory and Safety at Élan Pharmaceuticals. His career in the development of medical therapeutics began with training as a physician epidemiologist with an M.D. degree from Stanford University and an M.P.H. from the University of California, Berkeley. After his training in internal medicine, he was a member of the full-time faculty in the Schools of Medicine at the University of California at San Francisco and San Diego.
Professor Feigal later spent 12 years at the U.S. Food and Drug Administration, heading the Antiviral Drug Division, the Anti-Infective Drug Division and ODE IV in the Center for Drug Evaluation and Research, as Medical Deputy Director in the Center for Biologics Research and Evaluation and serving as the Director of the Center for Devices and Radiological Health from 1999 to 2004.
B.A. University of Minnesota
M.D., Stanford University
M.P.H., University of California, Berkeley